Ricevi le ultime notizie sulle azioni CytoSorbents con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di CTSO

Ultime notizie per

CYTOSORBENTS CORP

CytoSorbents

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

CytoSorbents Corp

Press Releases

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Leads a New Era in Sepsis Treatment

Earnings

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Small Cap

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CytoSorbents Provides DrugSorb-ATR Regulatory Update

Penny Stocks

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

CTSO

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Apyx Medical

Baird Medical Investment Holdings Ltd - Ordinary Share

Baird Medical Investment

HeartBeam

Daxor

electroCore

EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share

Edap TMS

Fonar

Icecure Medical

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares

Inspira Technologies Oxy

Lucid Diagnostics

Pulmonx

Spectral AI

Milestone Scientific

Modular Medical

Myomo

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

Neuraxis

Odysight ai

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Sensus Healthcare

Vivani Medical

JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares

Jin Medical International

Zynex

D. Boral Capital

HC Wainwright & Co.

EF Hutton

B. Riley Securities

Comments

CytoSorbents Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO